Vimarsana
Biggest News Aggregation in the World

Page 25 - Michelle Mitchell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michelle Mitchell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michelle Mitchell Today - Breaking & Trending Today

U.K. researchers get funding for lung cancer vaccine development - Vimarsana News

U.K. researchers get funding for lung cancer vaccine development

Researchers are working to develop a lung cancer vaccine in the U.K. with 1.7 million pounds ($2.2 million) funding from leading charities.

Cancer Research UK Manchester Centre to receive £8.5m boost for clinician scientist training - Vimarsana News

Cancer Research UK Manchester Centre to receive £8.5m boost for clinician scientist training

5.04.2024 - Scientist hand in blue gloves holding coronavirus, covid-19 vaccine disease, preparing for human clinical trials vaccination shot. Medicine and drug concept.

Bowel cancer deaths and cases to soar by a TENTH in by 2040 amid spiralling obesity rates, charity warns - Vimarsana News

Bowel cancer deaths and cases to soar by a TENTH in by 2040 amid spiralling obesity rates, charity warns

Analysis released by the Bowelbabe Fund - set up in memory of Deborah James - projected that if current trends continue, bowel cancer cases will rise to 47,700.

Bowelbabe Fund highlights growing bowel cancer numbers - Vimarsana News

Bowelbabe Fund highlights growing bowel cancer numbers

Cases are set to increase by a tenth due to a growing and ageing population.

UCL Secures £1.7 Million Funding for Vaccine Development to Prevent Lung Cancer - Vimarsana News

UCL Secures £1.7 Million Funding for Vaccine Development to Prevent Lung Cancer

The ‘LungVax’ vaccine uses technology similar to the highly successful Oxford/AstraZeneca COVID-19 vaccine. The team will receive funding for the study over the next two years to support lab research and initial manufacturing of 3,000 doses of the va